Profiel
Christine Conroy worked as a Senior Director of Regulatory Affairs at Genitope Corp.
from 2002 to 2004.
Prior to that, she was a Regulatory Program Director at Roche Global Development from 1995 to 2001.
From 2009 to 2013, she served as the VP of Regulatory Affairs & Good Clinical Practice at Affymax, Inc. In addition, she was the Manager of the Medical Services Department at Syntex Laboratories, Inc. from 1989 to 1994.
Most recently, she worked as the Senior Vice President of Regulatory Affairs at Dermira, Inc. from 2014 to 2018.
Conroy holds a doctorate degree from KU School of Pharmacy and an undergraduate degree from the University of Colorado School of Pharmacy.
Eerdere bekende functies van Christine Conroy
| Bedrijven | Functie | Einde |
|---|---|---|
| DERMIRA, INC. | General Counsel | 01-09-2018 |
| GENITOPE CORPORATION | General Counsel | 01-01-2004 |
| Roche Global Development | Corporate Officer/Principal | 01-01-2001 |
| Syntex Laboratories, Inc. | Corporate Officer/Principal | 01-01-1994 |
| AFFYMAX, INC. | General Counsel | - |
Opleiding van Christine Conroy
| KU School of Pharmacy | Doctorate Degree |
| University of Colorado School of Pharmacy | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
| Syntex Laboratories, Inc. | |
| Roche Global Development | |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
